RBC Bioscience Corporation researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia. It offers molecular biomedical diagnostic and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues; automated nucleic acid extractors; and nucleic acid extraction kits. The company sells its products through distributors. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.
Stock data | 2024 | Change |
---|---|---|
Price | $0.6378368575904149 | N/A |
Market Cap | $8.28M | N/A |
Shares Outstanding | 12.98M | N/A |
Employees | 0 | N/A |